Merz Therapeutics GmbH
5 products tracked · names used in filings: Merz Therapeutics GmbH, Merz Pharmaceuticals GmbH
Upcoming milestones
No upcoming milestones listed.
Recent milestones
No recent milestones.
Products
| Product | Status | Approved | |
|---|---|---|---|
| 🇪🇺 | Balaxur memantine hydrochloride;donepezil hydrochloride | Refused | |
| 🇪🇺 | Inbrija levodopa | Authorised | 2019-09-19 |
| 🇪🇺 | Memantine Merz memantine hydrochloride | Authorised | 2012-11-22 |
| 🇪🇺 | Fampyra fampridine | Authorised | 2011-07-20 |
| 🇪🇺 | Axura memantine | Authorised | 2002-05-17 |
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.